Article

Efficacy Thresholds for Cost-Saving Antiviral SARS-CoV-2 Treatment Strategies: A Modelling Study

2023-09-19

Abstract excerpt

Background: In 2023 SARS-CoV-2 was declared endemic, yet hospital admissions persist within high-risk and moderate-risk populations. Antiviral treatments, currently only available for high-risk individuals, play an important role in preventing severe disease and hospitalisation within this subpopulation. Here, we further explore the public health and economic benefits of extending target populations for treatment,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2051e497-d7fa-576a-8cc1-759c2abe38e3
DOI: 10.2139/ssrn.4572852

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy Thresholds for Cost-Saving Antiviral SARS-CoV-2 Treatment Strategies: A Modelling StudyDOI 10.2139/ssrn.4572852Read

Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling studySemantic proximity Read

Epidemiological characteristics of three SARS-CoV-2 variants of concern and implications for future COVID-19 pandemic outcomesSemantic proximity Read

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in CanadaSemantic proximity Read

Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling studySemantic proximity Read

Cost Effective Proactive Testing Strategies During COVID-19 Mass Vaccination: A Modelling StudySemantic proximity Read

Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling StudySemantic proximity Read

COVIDStrategyCalculator: A software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolationSemantic proximity Read

Risk of SARS-CoV-2 Infection and Hospitalization in Individuals with Natural, Vaccine-Induced and Hybrid Immunity: A Retrospective Nationwide Study from EstoniaSemantic proximity Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

Vaccination and Non-Pharmaceutical Interventions: When can the UK relax about COVID-19?Semantic proximity Read

Public health actions to control new SARS-CoV-2 variantsSemantic proximity Read

Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variantsSemantic proximity Read